Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page
- Check11 days agoChange DetectedAdded a glossary toggle and new data-provenance fields (Last Update Submitted that Met QC Criteria, Last Update Posted); the older QC-field label and No FEAR Act data were removed, and the site revision is now shown as Revision: v3.4.0.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now lists Revision: v3.3.4 and removes Revision: v3.3.3, indicating a minor update to the protocol/documentation. No other substantive study details such as outcomes, enrollment, or eligibility appear to be changed.SummaryDifference0.0%

- Check47 days agoChange DetectedLocation listings were updated to add numerous sites across the United States, Australia, and various other countries. Several existing sites were removed.SummaryDifference2%

- Check68 days agoChange DetectedRevision: v3.3.2 has been added. Revision: v3.3.1 has been removed.SummaryDifference0.0%

- Check75 days agoChange DetectedA note was added clarifying that publications are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded Tainan, Taiwan, 70403 as a study location and replaced the entry 'Tainan City, Taiwan, 70403' with 'Tainan, Taiwan, 70403' in the location list.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.